vs
Side-by-side financial comparison of GLADSTONE COMMERCIAL CORP (GOOD) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $43.5M, roughly 1.9× GLADSTONE COMMERCIAL CORP). GLADSTONE COMMERCIAL CORP runs the higher net margin — 12.4% vs -38.1%, a 50.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 16.3%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 10.3%).
Gladstone Commercial Corp is a publicly traded US real estate investment trust focused on acquiring, owning, and operating diversified industrial and commercial properties. It offers long-term net lease agreements to tenants across manufacturing, logistics, healthcare and professional services sectors, mainly serving small to mid-sized business clients.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
GOOD vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $83.1M |
| Net Profit | $5.4M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 12.4% | -38.1% |
| Revenue YoY | 16.3% | 20.2% |
| Net Profit YoY | -25.1% | -27.9% |
| EPS (diluted) | $0.05 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $43.5M | $76.4M | ||
| Q3 25 | $40.8M | $83.3M | ||
| Q2 25 | $39.5M | $79.2M | ||
| Q1 25 | $37.5M | $69.2M | ||
| Q4 24 | $37.4M | $68.2M | ||
| Q3 24 | $39.2M | $58.4M | ||
| Q2 24 | $37.1M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $5.4M | $-29.8M | ||
| Q3 25 | $4.1M | $-21.4M | ||
| Q2 25 | $4.6M | $-19.6M | ||
| Q1 25 | $5.1M | $-24.7M | ||
| Q4 24 | $7.2M | $-18.9M | ||
| Q3 24 | $11.7M | $-21.0M | ||
| Q2 24 | $1.6M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | — | -27.8% | ||
| Q2 25 | — | -28.0% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | — | -38.4% | ||
| Q2 24 | — | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 12.4% | -39.1% | ||
| Q3 25 | 10.1% | -25.7% | ||
| Q2 25 | 11.7% | -24.7% | ||
| Q1 25 | 13.7% | -35.8% | ||
| Q4 24 | 19.2% | -27.6% | ||
| Q3 24 | 29.8% | -35.9% | ||
| Q2 24 | 4.3% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.05 | $-0.54 | ||
| Q3 25 | $0.02 | $-0.38 | ||
| Q2 25 | $0.03 | $-0.35 | ||
| Q1 25 | $0.04 | $-0.45 | ||
| Q4 24 | $0.10 | $-0.34 | ||
| Q3 24 | $0.20 | $-0.40 | ||
| Q2 24 | $-0.04 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.8M | $245.6M |
| Total DebtLower is stronger | $843.5M | $51.7M |
| Stockholders' EquityBook value | $171.8M | $347.7M |
| Total Assets | $1.2B | $487.1M |
| Debt / EquityLower = less leverage | 4.91× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $10.8M | $286.5M | ||
| Q3 25 | $18.4M | $294.3M | ||
| Q2 25 | $11.7M | $302.7M | ||
| Q1 25 | $10.4M | $316.2M | ||
| Q4 24 | $11.0M | $333.7M | ||
| Q3 24 | $10.5M | $196.8M | ||
| Q2 24 | $10.4M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $843.5M | $51.6M | ||
| Q3 25 | $843.3M | $51.6M | ||
| Q2 25 | $794.4M | $51.5M | ||
| Q1 25 | $740.7M | $51.5M | ||
| Q4 24 | $693.4M | $51.5M | ||
| Q3 24 | $692.6M | $51.4M | ||
| Q2 24 | $722.5M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $171.8M | $365.9M | ||
| Q3 25 | $184.8M | $380.3M | ||
| Q2 25 | $177.2M | $385.8M | ||
| Q1 25 | $183.2M | $389.2M | ||
| Q4 24 | $171.2M | $402.2M | ||
| Q3 24 | $168.9M | $241.2M | ||
| Q2 24 | $145.7M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $1.2B | $508.1M | ||
| Q3 25 | $1.3B | $511.5M | ||
| Q2 25 | $1.2B | $513.1M | ||
| Q1 25 | $1.2B | $519.4M | ||
| Q4 24 | $1.1B | $534.0M | ||
| Q3 24 | $1.1B | $374.1M | ||
| Q2 24 | $1.1B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 4.91× | 0.14× | ||
| Q3 25 | 4.56× | 0.14× | ||
| Q2 25 | 4.48× | 0.13× | ||
| Q1 25 | 4.04× | 0.13× | ||
| Q4 24 | 4.05× | 0.13× | ||
| Q3 24 | 4.10× | 0.21× | ||
| Q2 24 | 4.96× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $88.2M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 16.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $88.2M | $-10.3M | ||
| Q3 25 | $18.9M | $-6.6M | ||
| Q2 25 | $35.8M | $-15.0M | ||
| Q1 25 | $17.7M | $-17.0M | ||
| Q4 24 | $57.0M | $-32.4M | ||
| Q3 24 | $5.5M | $-18.8M | ||
| Q2 24 | $13.6M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 16.38× | — | ||
| Q3 25 | 4.57× | — | ||
| Q2 25 | 7.74× | — | ||
| Q1 25 | 3.44× | — | ||
| Q4 24 | 7.93× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 8.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GOOD
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
